ivm medium Search Results


90
ORIGIO Inc ivm medium
(a) The COCs at egg retrieval (day 0), showing signs of immaturity. (b) The first COC 23 hours <t>post-IVM</t> before denudation, showing a first polar body, indicated by a white arrow (mature MII oocyte). (c) The second COC 23 hours post-IVM being immature at the GV stage. (d) The oocyte after denudation, with the first polar body at a 12-hour position before ICSI. (e) Normal fertilization indicated by the presence of two pronuclei 16 hours post-ICSI. (f) Development of the fertilized oocyte to the blastocyst stage. IVM, in vitro maturation; ICSI, intracytoplasmic sperm injection; COC, cumulus-oocyte complex; MII, metaphase II; GV, germinal vesicle
Ivm Medium, supplied by ORIGIO Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ivm+medium/ivm+medium/pmc11343067-32-29-31
Average 90 stars, based on 1 article reviews
ivm medium - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Vitrolife Inc ivm medium
(a) The COCs at egg retrieval (day 0), showing signs of immaturity. (b) The first COC 23 hours <t>post-IVM</t> before denudation, showing a first polar body, indicated by a white arrow (mature MII oocyte). (c) The second COC 23 hours post-IVM being immature at the GV stage. (d) The oocyte after denudation, with the first polar body at a 12-hour position before ICSI. (e) Normal fertilization indicated by the presence of two pronuclei 16 hours post-ICSI. (f) Development of the fertilized oocyte to the blastocyst stage. IVM, in vitro maturation; ICSI, intracytoplasmic sperm injection; COC, cumulus-oocyte complex; MII, metaphase II; GV, germinal vesicle
Ivm Medium, supplied by Vitrolife Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ivm+medium/ivm+medium/nct03416400-2-6-13
Average 90 stars, based on 1 article reviews
ivm medium - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
CooperSurgical sage ivm medium
Summary of <t> IVM </t> oocyte vitrification studies.
Sage Ivm Medium, supplied by CooperSurgical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ivm+medium/sage+ivm+medium/pmc06650526-109-6-7
Average 90 stars, based on 1 article reviews
sage ivm medium - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
CooperSurgical ivm medium medicult ivm system maturation medium
Summary of <t> IVM </t> oocyte vitrification studies.
Ivm Medium Medicult Ivm System Maturation Medium, supplied by CooperSurgical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ivm+medium/ivm+medium+medicult+ivm+system+maturation+medium/pm32536541-34-6-13
Average 90 stars, based on 1 article reviews
ivm medium medicult ivm system maturation medium - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Merck KGaA ivm culture medium
Summary of <t> IVM </t> oocyte vitrification studies.
Ivm Culture Medium, supplied by Merck KGaA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ivm+medium/ivm+culture+medium/pm34052998-62-14-21
Average 90 stars, based on 1 article reviews
ivm culture medium - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
CooperSurgical ivm medium
Summary of <t> IVM </t> oocyte vitrification studies.
Ivm Medium, supplied by CooperSurgical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ivm+medium/ivm+medium/pm22197126-48-26-28
Average 90 stars, based on 1 article reviews
ivm medium - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Kitazato Corporation ivm culture medium kitazato cat.# sk-ivmc-50
Summary of <t> IVM </t> oocyte vitrification studies.
Ivm Culture Medium Kitazato Cat.# Sk Ivmc 50, supplied by Kitazato Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ivm+medium/IVM+culture+medium+Kitazato+cat++no++SK+IVMC+50/pmc09618666-48-7-10
Average 90 stars, based on 1 article reviews
ivm culture medium kitazato cat.# sk-ivmc-50 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
CooperSurgical conventional ivm medium
Summary of <t> IVM </t> oocyte vitrification studies.
Conventional Ivm Medium, supplied by CooperSurgical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ivm+medium/conventional+ivm+medium/pm21094941-40-13-18
Average 90 stars, based on 1 article reviews
conventional ivm medium - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Vitrolife Inc ivm medium supplemented with 75miu/ml fsh and lh
Description of cycle and outcome parameters.
Ivm Medium Supplemented With 75miu/Ml Fsh And Lh, supplied by Vitrolife Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ivm+medium/ivm+medium+supplemented+with+75miu+ml+fsh+and+lh/pmc04524709-12-63-54
Average 90 stars, based on 1 article reviews
ivm medium supplemented with 75miu/ml fsh and lh - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
CooperSurgical hepes-buffered oocyte washing medium ivm kit
Description of cycle and outcome parameters.
Hepes Buffered Oocyte Washing Medium Ivm Kit, supplied by CooperSurgical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ivm+medium/hepes+buffered+oocyte+washing+medium+ivm+kit/pm26848188-82-4-11
Average 90 stars, based on 1 article reviews
hepes-buffered oocyte washing medium ivm kit - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Corning Life Sciences ivm medium
Description of cycle and outcome parameters.
Ivm Medium, supplied by Corning Life Sciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ivm+medium/ivm+medium/pmc08718616-36-11-23
Average 90 stars, based on 1 article reviews
ivm medium - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
BIOSUPPLY UK LIMITED ivm medium
Description of cycle and outcome parameters.
Ivm Medium, supplied by BIOSUPPLY UK LIMITED, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ivm+medium/ivm+medium/pm25592974-53-5-7
Average 90 stars, based on 1 article reviews
ivm medium - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results


(a) The COCs at egg retrieval (day 0), showing signs of immaturity. (b) The first COC 23 hours post-IVM before denudation, showing a first polar body, indicated by a white arrow (mature MII oocyte). (c) The second COC 23 hours post-IVM being immature at the GV stage. (d) The oocyte after denudation, with the first polar body at a 12-hour position before ICSI. (e) Normal fertilization indicated by the presence of two pronuclei 16 hours post-ICSI. (f) Development of the fertilized oocyte to the blastocyst stage. IVM, in vitro maturation; ICSI, intracytoplasmic sperm injection; COC, cumulus-oocyte complex; MII, metaphase II; GV, germinal vesicle

Journal: Cureus

Article Title: Successful Pregnancy Following Platelet-Rich Plasma Intraovarian Injection and In Vitro Maturation of Oocytes in a 47-Year-Old Woman: A Case Report

doi: 10.7759/cureus.65281

Figure Lengend Snippet: (a) The COCs at egg retrieval (day 0), showing signs of immaturity. (b) The first COC 23 hours post-IVM before denudation, showing a first polar body, indicated by a white arrow (mature MII oocyte). (c) The second COC 23 hours post-IVM being immature at the GV stage. (d) The oocyte after denudation, with the first polar body at a 12-hour position before ICSI. (e) Normal fertilization indicated by the presence of two pronuclei 16 hours post-ICSI. (f) Development of the fertilized oocyte to the blastocyst stage. IVM, in vitro maturation; ICSI, intracytoplasmic sperm injection; COC, cumulus-oocyte complex; MII, metaphase II; GV, germinal vesicle

Article Snippet: The COCs were immature at oocyte retrieval (day 0), as expected, and they were subsequently cultured in LAG medium (Origio, Malov, Denmark) for three hours, followed by culture in IVM medium (Origio) for 22 hours in 6% CO 2 /7% O 2 at 37°C (Figure ).

Techniques: In Vitro, Injection

Summary of  IVM  oocyte vitrification studies.

Journal: Frontiers in Endocrinology

Article Title: Immature Oocyte for Fertility Preservation

doi: 10.3389/fendo.2019.00464

Figure Lengend Snippet: Summary of IVM oocyte vitrification studies.

Article Snippet: Recently, commercialized IVM media such as SAGE (Coopersurgical) IVM medium and Medi-Cult IVM medium have been used in several IVF centers as they have the advantage of being certified as IVF quality controlled ( – ).

Techniques: In Vivo, In Vitro, Activation Assay

Description of cycle and outcome parameters.

Journal: PLoS ONE

Article Title: In Vitro Maturation in Women with vs. without Polycystic Ovarian Syndrome: A Systematic Review and Meta-Analysis

doi: 10.1371/journal.pone.0134696

Figure Lengend Snippet: Description of cycle and outcome parameters.

Article Snippet: Buckett (2008) , IVM: PCOS (80%), Male (13%), Unexplained (6%), Tubal (1%); IVF: PCOS (8%), Male (11%), Unexplained (27%), Tubal (29%), Endom (12%), Poor Ovarian reverve (8%), other (5%); ICSI: Male (80%), Unexplained (10%), other (5%), PGD (4%), Endom (1%) , ESHRE/ASRM classification , NR , Other causes of subfertility , 10,000IU hCG , Vitrolife IVF medium , IVM Medium supplemented with 75mIU/ml FSH and LH for 24–48 hrs , Clinical miscarriage: pregnancy loss after ultrasonographic evidence of intrauterine pregnancy—gestational sac or fetal heartbeat; Late fetal loss: pregnancy loss after 12 weeks of gestation-including termination after congenital abnormality.

Techniques: Control, Saline, Activity Assay, Selection

(a). Comparison PCOS vs. non-PCOS regarding live birth rates (women-based analysis), stratified by stimulation with FSH. (b) Comparison PCOS vs. non-PCOS regarding live birth rates (women-based analysis), stratified by priming with hCG.

Journal: PLoS ONE

Article Title: In Vitro Maturation in Women with vs. without Polycystic Ovarian Syndrome: A Systematic Review and Meta-Analysis

doi: 10.1371/journal.pone.0134696

Figure Lengend Snippet: (a). Comparison PCOS vs. non-PCOS regarding live birth rates (women-based analysis), stratified by stimulation with FSH. (b) Comparison PCOS vs. non-PCOS regarding live birth rates (women-based analysis), stratified by priming with hCG.

Article Snippet: Buckett (2008) , IVM: PCOS (80%), Male (13%), Unexplained (6%), Tubal (1%); IVF: PCOS (8%), Male (11%), Unexplained (27%), Tubal (29%), Endom (12%), Poor Ovarian reverve (8%), other (5%); ICSI: Male (80%), Unexplained (10%), other (5%), PGD (4%), Endom (1%) , ESHRE/ASRM classification , NR , Other causes of subfertility , 10,000IU hCG , Vitrolife IVF medium , IVM Medium supplemented with 75mIU/ml FSH and LH for 24–48 hrs , Clinical miscarriage: pregnancy loss after ultrasonographic evidence of intrauterine pregnancy—gestational sac or fetal heartbeat; Late fetal loss: pregnancy loss after 12 weeks of gestation-including termination after congenital abnormality.

Techniques: Comparison

(a). Comparison PCOS vs. non-PCOS regarding clinical pregnancy rates (women-based analysis), stratified by stimulation with FSH. (b) Comparison PCOS vs. non-PCOS regarding clinical pregnancy rates (women-based analysis), stratified by priming with hCG.

Journal: PLoS ONE

Article Title: In Vitro Maturation in Women with vs. without Polycystic Ovarian Syndrome: A Systematic Review and Meta-Analysis

doi: 10.1371/journal.pone.0134696

Figure Lengend Snippet: (a). Comparison PCOS vs. non-PCOS regarding clinical pregnancy rates (women-based analysis), stratified by stimulation with FSH. (b) Comparison PCOS vs. non-PCOS regarding clinical pregnancy rates (women-based analysis), stratified by priming with hCG.

Article Snippet: Buckett (2008) , IVM: PCOS (80%), Male (13%), Unexplained (6%), Tubal (1%); IVF: PCOS (8%), Male (11%), Unexplained (27%), Tubal (29%), Endom (12%), Poor Ovarian reverve (8%), other (5%); ICSI: Male (80%), Unexplained (10%), other (5%), PGD (4%), Endom (1%) , ESHRE/ASRM classification , NR , Other causes of subfertility , 10,000IU hCG , Vitrolife IVF medium , IVM Medium supplemented with 75mIU/ml FSH and LH for 24–48 hrs , Clinical miscarriage: pregnancy loss after ultrasonographic evidence of intrauterine pregnancy—gestational sac or fetal heartbeat; Late fetal loss: pregnancy loss after 12 weeks of gestation-including termination after congenital abnormality.

Techniques: Comparison